RxDoctor Payments Data

Edward Hobgood, MD

Orthopaedic Surgery · Jackson, MSNPI 1578502407

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $202,813 of the $266,797 with a category attached, or 76.0%. Smith+Nephew accounts for 95.7% of it on its own, with 2 other manufacturers making up the rest. 2025 is the largest year on record at $138,653, more than ten times the $11,483 reported in 2019. Among orthopaedic surgery clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$266,797in general payments, 2019–2025

Across 112 payments — averaging $2382.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$255K
  • Integra Lifesciences Corporation$11K
  • Exactech, Inc.$81
$134,576in research payments, 2019–2025

Across 27 payments — averaging $4984.31 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Zimmer Biomet$73K
  • Smith+Nephew$47K
  • Exactech, Inc.$15K

What the payments were for

  • Royalty or licence$202,81376%
  • Consulting fees$45,48817%
  • Speaking & faculty fees$13,4255%
  • Travel & lodging$3,3881%
  • Food & beverage$1,6841%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew85$255,249
Integra Lifesciences Corporation26$11,468
Exactech, Inc.1$81

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$266,797 in reported general payments places this provider in the 95th percentile of 170 orthopaedic surgery providers in Mississippi.

See all orthopaedic surgery providers in Mississippi

Medicare billing

Part B allowed, 2024
$394,912
Medicare patients
759
Services billed
24,082

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen153$1,743
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen71$527
Cefadroxil54$419
Ondansetron OdtOndansetron68$256
Methylprednisolone27$186
Ondansetron Hcl73$122
Tramadol Hcl53$112
Meloxicam49$88
Promethazine Hcl17$24
Alprazolam12$4

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →